Chinese Biotech Firm Biothus Raises $26M In A New Round

Login to View

Biothus, a Chinese biotech firm, has raised RMB180 million (US$25.83 million) in a new funding round from a Zhuhai government-owned investment firm, Highlight Capital, a venture capital firm, and Zhuhai Huajin Asset Co. Ltd. 

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Read 2 Articles for Free with a Basic Account

Gain limited and restricted access to China Money Network.

Register Basic Account

Subscribe for an annual subscription!

Enjoy comprehensive and exclusive data you can't find elsewhere!

More Info

Subscribe and Pay Easily Online!

Already have an account or paid subscription? Log in



  1. This is journalist, author and global cancer patient advocate Jamie Reno. I would like to contact Biothus, there is very little information online about the company. Is there a website? A contact email? Many thanks. Jamie